SIA "Contract Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2011–2025
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||||
| Total current assets | 1 025 849 | 971 049 | 924 413 | 1 314 028 | 1 313 980 | 1 319 171 | 1 200 150 | 1 216 056 | 129 593 | 81 046 | 50 578 | 1 532 057 | 325 907 | 346 803 | 213 678 |
| Total non-current assets | 1 460 768 | 1 460 555 | 1 460 555 | 2 078 183 | 2 078 183 | 2 078 183 | 2 078 183 | 2 078 183 | 5 039 899 | 7 882 171 | 8 043 735 | 7 999 369 | 5 232 822 | 8 146 781 | 20 245 298 |
| Total assets | 2 486 617 | 2 431 604 | 2 384 968 | 3 392 211 | 3 392 163 | 3 397 354 | 3 278 333 | 3 294 239 | 5 169 492 | 7 963 217 | 8 094 313 | 9 531 426 | 5 558 729 | 8 493 584 | 20 458 976 |
| Balance sheet — liabilities and equity | |||||||||||||||
| Current liabilities | 0 | 2 969 484 | 143 074 | 210 746 | 230 | 627 243 | 820 943 | 815 043 | 1 161 981 | 7 770 243 | 7 873 087 | 9 268 289 | 4 303 928 | 6 871 244 | 7 966 474 |
| Non-current liabilities | 2 860 558 | 0 | 2 776 031 | 3 949 936 | 4 168 936 | 4 176 906 | 4 107 906 | 3 448 906 | 4 302 105 | 0 | 0 | 0 | 0 | 0 | 10 390 303 |
| Total liabilities | 2 860 558 | 2 969 484 | 2 919 105 | 4 160 682 | 4 169 166 | 4 804 149 | 4 928 849 | 4 263 949 | 5 464 086 | 7 770 243 | 7 873 087 | 9 268 289 | 4 303 928 | 6 871 244 | 18 356 777 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -117 416 | -163 939 | 3742 | -8462 | -8533 | -629 787 | -243 721 | 680 807 | 675 116 | 487 568 | 28 251 | 41 911 | 991 664 | 367 539 | 479 859 |
| Total equity | -373 941 | -537 880 | -534 137 | -768 471 | -777 003 | -1 406 795 | -1 650 516 | -969 710 | -294 594 | 192 974 | 221 226 | 263 137 | 1 254 801 | 1 622 340 | 2 102 199 |
| Income statement | |||||||||||||||
| Sales revenue | 94 879 | 0 | 57 630 | 0 | 0 | 6400 | 209 364 | 725 981 | 843 801 | 986 354 | 497 327 | 621 612 | 927 712 | 929 960 | 1 020 694 |
| Operating profit | 44 798 | -4382 | 6651 | -3219 | -3241 | -2783 | -68 235 | 680 807 | 675 116 | 487 568 | 28 251 | 43 551 | 112 326 | -172 746 | 508 517 |
| Profit before income tax | -113 188 | -161 031 | 6652 | -3219 | -3241 | -629 787 | -243 721 | 680 807 | 675 116 | 487 568 | 28 251 | 41 911 | 991 788 | 367 567 | 479 881 |
| Profit for the reporting year | -117 416 | -163 939 | 3742 | -8462 | -8533 | -629 787 | -243 721 | 680 807 | 675 116 | 487 568 | 28 251 | 41 911 | 991 664 | 367 539 | 479 859 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||||
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 7 | 15 | 18 | 19 | 20 | 23 | 24 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- SIA "Pharma VC" — 75%
- SIA "2012" — 50%
- SIA "JAUNIE EZERKRASTI" — 3 shared people
- SIA "SAULES APTIEKA" — 2 shared people
- "CILMES ŠŪNU TEHNOLOĢIJU UN SPECIĀLISTU ASOCIĀCIJA"
- "Dr.G.B. konsultācijas," SIA
- "Mednieku klubs "Hiršenhofa""
- Latvijas Aptiekāru asociācija
- SIA "2012"
- SIA "ABC pharma"
- SIA "BALTAIS BRIEDIS"
- SIA "Baltacon"
- SIA "GLOBAL FINANCE HQ"
- SIA "INNOVATIVE BUSINESS CONSULTING"
Summary: SIA "Contract Pharma"
Overview
SIA "Contract Pharma" (reg. no. 40003777733) is a limited liability company. The company was registered in 2005 and has been in the register for 21 years. Registered address: Rīga, Krūzes iela 38.
Financial results
Revenue in 2025 was 1 020 694 €, up 9,8% on the previous year (929 960 €). From 2011 to 2025, revenue grew by an average of 18,5% per year. This is the company's highest revenue among the published years (2011–2025). Net profit for 2025 was 479 859 € (47,0% of revenue). The company was profitable in 9 of the 15 published years. In 2025 the company had 24 employees (23 a year earlier). Revenue per employee was 42 529 €. At the end of 2025, total assets were 20 458 976 € and equity 2 102 199 € (10,3% of assets).
Management and owners
The board has 3 members. The sole owner of the company is a private individual. The company holds stakes in 2 active Latvian companies.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.